Autoantibody-induced intestinal inflammation and weight loss in experimental epidermolysis bullosa acquisita

Journal of Pathology

Volumn 224, Issue 2, 2011, Pages 234-244

  Ishii, Norito ^a,b   Recke, Andreas ^a   Mihai, Sidonia ^a   Hirose, Misa ^a   Hashimoto, Takashi ^b   Zillikens, Detlef ^a   Ludwig, Ralf J ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

autoimmunity; colitis; epidermolysis bullosa acquisita; gut; type VII collagen

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 7; COLLAGEN TYPE 7 ANTIBODY; IMMUNOGLOBULIN G; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CHEEK MUCOSA; COLON; CONTROLLED STUDY; ENTERITIS; EPIDERMOLYSIS BULLOSA ACQUISITA; ESOPHAGUS; INFLAMMATION; LEUKOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE; STOMACH; WEIGHT REDUCTION;

ANIMALS; AUTOANTIBODIES; BLISTER; COLITIS; COLLAGEN TYPE VII; COLON; COMPLEMENT C3; DISEASE MODELS, ANIMAL; EPIDERMOLYSIS BULLOSA ACQUISITA; ESOPHAGUS; GENE EXPRESSION; IMMUNOGLOBULIN G; LEUKOCYTES; MACROPHAGES; MICE; MICE, INBRED BALB C; RNA, MESSENGER; WEIGHT LOSS;

EID: 79955792085     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2857     Document Type: Article

References (44)

1. Ryynanen M, Ryynanen J, Sollberg S, et al., Genetic linkage of type VII collagen (COL7A1) to dominant dystrophic epidermolysis bullosa in families with abnormal anchoring fibrils. J Clin Invest 1992; 89: 974-980.
2. Dang N, Murrell DF,. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa. Exp Dermatol 2008; 17: 553-568.
3. Heinonen S, Mannikko M, Klement JF, et al., Targeted inactivation of the type VII collagen gene (Col7a1) in mice results in severe blistering phenotype: a model for recessive dystrophic epidermolysis bullosa. J Cell Sci 1999; 112: 3641-3648.
4. Woodley DT, Remington J, Chen M,. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Clin Rev Allergy Immunol 2007; 33: 78-84.
5. Sitaru C, Zillikens D,. Mechanisms of blister induction by autoantibodies. Exp Dermatol 2005; 14: 861-875. (Pubitemid 41723203)
6. Woodley DT, Burgeson RE, Lunstrum G, et al., Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988; 81: 683-687. (Pubitemid 18079715)
7. Gammon WR, Murrell DF, Jenison MW, et al., Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J Invest Dermatol 1993; 100: 618-622. (Pubitemid 23128355)
8. Lapiere JC, Woodley DT, Parente MG, et al., Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993; 92: 1831-1839. (Pubitemid 23304550)
9. Tanaka T, Furukawa F, Imamura S,. Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. J Invest Dermatol 1994; 102: 706-709. (Pubitemid 24144247)
10. Mihai S, Chiriac MT, Takahashi K, et al., The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita. J Immunol 2007; 178: 6514-6521. (Pubitemid 46717435)
11. Chiriac MT, Roesler J, Sindrilaru A, et al., NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol 2007; 212: 56-65. (Pubitemid 46746290)
12. Shimanovich I, Mihai S, Oostingh GJ, et al., Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 2004; 204: 519-527. (Pubitemid 39585950)
13. Paller AS, Queen LL, Woodley DT, et al., Organ-specific, phylogenetic, and ontogenetic distribution of the epidermolysis bullosa acquisita antigen. J Invest Dermatol 1986; 86: 376-379. (Pubitemid 16050012)
14. Visser R, Arends JW, Leigh IM, et al., Patterns and composition of basement membranes in colon adenomas and adenocarcinomas. J Pathol 1993; 170: 285-290. (Pubitemid 23234876)
15. Lohi J, Leivo I, Tani T, et al., Laminins, tenascin and type VII collagen in colorectal mucosa. Histochem J 1996; 28: 431-440. (Pubitemid 26280859)
16. Leivo I, Tani T, Laitinen L, et al., Anchoring complex components laminin-5 and type VII collagen in intestine: association with migrating and differentiating enterocytes. J Histochem Cytochem 1996; 44: 1267-1277. (Pubitemid 26376352)
17. Wetzels RH, Robben HC, et al., Distribution patterns of type VII collagen in normal and malignant human tissues. Am J Pathol 1991; 139: 451-459.
18. Chen M, O'Toole EA, Sanghavi J, et al., The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with Crohn's disease have autoantibodies to type VII collagen. J Invest Dermatol 2002; 118: 1059-1064. (Pubitemid 34639186)
19. Sherry F, Dothridge MD,. Case for diagnosis: epidermolysis bullosa acquisita. Proc R Soc Med 1962; 55: 409.
20. Labeille B, Gineston JL, Denoeux JP, et al., Epidermolysis bullosa acquisita and Crohn's disease. A case report with immunological and electron microscopic studies. Arch Intern Med 1988; 148: 1457-1459.
21. Sitaru C, Mihai S, Otto C, et al., Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J Clin Invest 2005; 115: 870-878. (Pubitemid 40489391)
22. Woodley DT, Chang C, Saadat P, et al., Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005; 124: 958-964. (Pubitemid 40629096)
23. Woodley DT, Ram R, Doostan A, et al., Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients. J Invest Dermatol 2006; 126: 1323-1330. (Pubitemid 43997915)
24. Sitaru C, Chiriac MT, Mihai S, et al., Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol 2006; 177: 3461-3468. (Pubitemid 44277867)
25. Recke A, Sitaru C, Vidarsson G, et al., Pathogenicity of IgG subclass autoantibodies to type VII collagen: induction of dermal-epidermal separation. J Autoimmun 2010; 34: 435-444.
26. Alban S, Ludwig RJ, Bendas G, et al., PS3, a semisynthetic beta-1,3-glucan sulfate, diminishes contact hypersensitivity responses through inhibition of L- and P-selectin functions. J Invest Dermatol 2009; 129: 1192-1202.
27. Conlan JW, North RJ,. Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J Exp Med 1994; 179: 259-268.
28. Czuprynski CJ, Brown JF, Maroushek N, et al., Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J Immunol 1994; 152: 1836-1846. (Pubitemid 24075716)
29. Ludwig RJ, Zollner TM, Santoso S, et al., Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation. J Invest Dermatol 2005; 125: 969-976.
30. Leigh IM, Purkis PE, Bruckner-Tuderman L,. LH7.2 monoclonal antibody detects type VII collagen in the sublamina densa zone of ectodermally-derived epithelia, including skin. Epithelia 1987; 1: 17-19.
31. Braegger CP, MacDonald TT,. Immune mechanisms in chronic inflammatory bowel disease. Ann Allergy 1994; 72: 135-141. (Pubitemid 24065474)
32. Bouma G, Strober W,. The immunological and genetic basis of inflammatory bowel disease. Nature Rev Immunol 2003; 3: 521-533. (Pubitemid 37328672)
33. Targan SR, Landers CJ, Cobb L, et al., Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. J Immunol 1995; 155: 3262-3267.
34. Aldebert D, Masy E, Reumaux D, et al., Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease. Dig Dis Sci 1997; 42: 2350-2355. (Pubitemid 28004999)
35. Biancone L, Monteleone G, Marasco R, et al., Autoimmunity to tropomyosin isoforms in ulcerative colitis (UC) patients and unaffected relatives. Clin Exp Immunol 1998; 113: 198-205. (Pubitemid 28352837)
36. Quinton JF, Sendid B, Reumaux D, et al., Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998; 42: 788-791. (Pubitemid 28277217)
37. Fricke H, Birkhofer A, Folwaczny C, et al., Characterization of antigens from the human exocrine pancreatic tissue (Pag) relevant as target antigens for autoantibodies in Crohn's disease. Eur J Clin Invest 1999; 29: 41-45. (Pubitemid 29084247)
38. Oostingh GJ, Sitaru C, Zillikens D, et al., Subclass distribution of type VII collagen-specific autoantibodies in patients with inflammatory bowel disease. J Dermatol Sci 2005; 37: 182-184. (Pubitemid 40331930)
39. Raab B, Fretzin DF, Bronson DM, et al., Epidermolysis bullosa acquisita and inflammatory bowel disease. J Am Med Assoc 1983; 250: 1746-1748. (Pubitemid 13007014)
40. Schattenkirchner S, Lemann M, Prost C, et al., Localized epidermolysis bullosa acquisita of the esophagus in a patient with Crohn's disease. Am J Gastroenterol 1996; 91: 1657-1659. (Pubitemid 26269195)
41. Livden JK, Nilsen R, Thunold S, et al., Epidermolysis bullosa acquisita and Crohn's disease. Acta Derm Venereol 1978; 58: 241-244. (Pubitemid 8406387)
42. Hughes BR, Horne J,. Epidermolysis bullosa acquisita and total ulcerative colitis. J R Soc Med 1988; 81: 473-475.
43. Bieber K, Sun S, Ishii N, et al., Animal models for autoimmune bullous dermatoses. Exp Dermatol 2010; 19: 2-11.
44. Amagai M, Tsunoda K, Suzuki H, et al., Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J Clin Invest 2000; 105: 625-631. (Pubitemid 30146509)